Organizations need to monitor and administer their software throughout departments because today's technology-based ...

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ: TBPH), today announced that it will be presenting two rapid-fire presentations at CHEST 2025, the annual meeting of the ...

Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that VEOZAHtm (fezolinetant), its first-in-class, targeted, non-hormonal treatment for moderate to severe ...

Epista Life Science today announced one of the pharmaceutical industry's most comprehensive clinical data remediation programs, a multi-phase initiative spanning more than 800 studies, 43,000 study ...

Oracle Health has launched its new Connection Hub, a tool designed to help U.S. healthcare providers manage and share patient data through a single console. The platform aims to simplify ...

Gilead Sciences and Arcus Biosciences’ anti-TIGIT antibody domvanalimab has been tied to median overall survival of close to ...

Pivotal ADAPT SERON results and interim ADAPT Jr data showcase VYVGART’s potential to treat broad set of myasthenia gravis patientsReal-world ...

The Office of Management and Budget in 2020 and 2021 teamed with agency chief information officers and chief data officers to ...

Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...

Given the unmet need of fatigue in primary biliary cholangitis (PBC), the PBC working group of the European Reference Network for Rare Liver Diseases assessed and summarised the current evidence ...

Posters will be presented on Thursday, October 23, 6:15 – 7:15 PM.

Cardiovascular disease (CVD) continues to be the world’s leading cause of death, presenting a significant challenge to global health systems. Traditional ...